# Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

> **NCT04083157** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 104 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Hepatitis B

## Interventions

- **BIOLOGICAL:** Intradermal hepatitis B vaccine with imiquimod
- **BIOLOGICAL:** Intramuscular hepatitis B vaccine with aqueous cream

## Key facts

- **NCT ID:** NCT04083157
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04083157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04083157, "Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04083157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*